Stanley Erck

Novavax May Get Approval In 2 Months, Likely To Cost More Than Covishield

Left, Right & Centre

5 years ago

Novavax May Get Approval In 2 Months, Likely To Cost More Than Covishield

novavax ceo to ndtv

american vaccine-maker

stanley erck

ceo of novavax

novavax vaccine

+5

+5

+4

+4

+4

+3

+3

+3

+2

10:27

novavax ceo to ndtv

american vaccine-maker

stanley erck

ceo of novavax

novavax vaccine

+5

+5

+4

+4

+4

+3

+3

+3

+2